49 research outputs found

    Characterization of South American Snails of the Genus Biomphalaria

    Get PDF
    The identification of snails of the genus Biomphalaria can be done using morphological characteristics which depends on the size of the snails and skill and knowledge of researcher. These methods sometimes are not adequate for identification of species. The PCR-RFLP, using the ITS region of the rDNA, has been used to identify Brazilian species of the genus Biomphalaria. Nevertheless, there is a lack of information about snails from other Latin American countries. In addition, some snails may be infected by Schistosoma mansoni and when submitted to PCR-RFLP they show molecular profiles different from those previously standardized for the other mollusc species. In this work the molecular profiles of 15 species and the subspecies were established by PCR-RFLP of ITS-rDNA with the enzyme DdeI. Moreover, the molecular profiles of host species, B. glabrata, B. straminea, B. tenagophila, and B. prona, infected by S. mansoni were also established. The molluscs were dissected to permit morphological identification. These results contribute to a correct identification of snails of the genus Biomphalaria and detection of these snails infected by S. mansoni

    Nandrolone and resistance training induce heart remodeling: Role of fetal genes and implications for cardiac pathophysiology

    Get PDF
    Aims: This study was conducted to assess the isolated and combined effects of nandrolone and resistance training on cardiac morphology, function, and mRNA expression of pathological cardiac hypertrophy markers.Main methods: Wistar rats were randomly divided into four groups and submitted to 6 weeks of treatment with nandrolone and/or resistance training. Cardiac parameters were determined by echocardiography. Heart was analyzed for collagen infiltration. Real-time RT-PCR was used to assess the pathological cardiac hypertrophy markers.Key findings: Both resistance training and nandrolone induced cardiac hypertrophy. Nandrolone increased the cardiac collagen content, and reduced the cardiac index in non-trained and trained groups, when compared with the respective vehicle-treated groups. Nandrolone reduced the ratio of maximum early to late transmitral flow velocity in non-trained and trained groups, when compared with the respective vehicle-treated groups. Nandrolone reduced the alpha-myosin heavy chain gene expression in both non-trained and trained groups, when compared with the respective vehicle-treated groups. Training reduced the beta-myosin heavy chain gene expression in the groups treated with vehicle and nandrolone. Only the association between training and nandrolone increased the expression of the skeletal alpha-actin gene and atrial natriuretic peptide in the left ventricle.Significance: This study indicated that nandrolone, whether associated with resistance training or not, induces cardiac hypertrophy, which is associated with enhanced collagen content, re-expression of fetal genes the in left ventricle, and impaired diastolic and systolic function. (C) 2011 Elsevier Inc. All rights reserved.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FAEPEX/UNICAMPConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Univ Estadual Campinas, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, BrazilUniv São Paulo, Sch Med, Heart Inst InCor, Hypertens Unit, São Paulo, SP, BrazilUniversidade Federal de São Paulo, Inst Sci & Technol, São Paulo, SP, BrazilUniv São Paulo, Sch Phys Educ & Sports, Biochem Lab, São Paulo, SP, BrazilUniv Estadual Campinas, Piracicaba Dent Sch, Dept Morphol, Piracicaba, SP, BrazilPontifical Catholic Univ Campinas, Life Sci Ctr, Campinas, SP, BrazilUniversidade Federal de São Paulo, Inst Sci & Technol, São Paulo, SP, BrazilFAPESP: 05/60284-6Web of Scienc

    Avaliação da marcha e do equilíbrio de pacientes idosos com osteoartrose de joelho / Evaluation of gait and balance of elderly patients with knee osteoarthritis

    Get PDF
    Objetivo: O estudo objetiva, avaliar o equilíbrio e a marcha em indivíduos idosos com osteoartrose de joelho. Metodologia: Estudo do tipo observacional, descritivo e  de corte transversal. Constituída por: palestra explicativa; assinatura do Termo de Consentimento Livre e Esclarecido; coleta de dados sociodemográficos; aplicação das escalas: Tinetti e Berg; e, ao final à análise descritiva e estatística dos dados coletados. Resultados: A amostra foi composta por 19 indivíduos idosos, com predominância feminina (84,2%), com média de idade de 69,74±6,31 anos, Índice de Massa Corpórea (IMC) de 30,81±z5,64Kg/m² (obeso) e 84,2% não realiza nenhum tipo de atividade física. O teste de Tinetti e a escala de Berg apresentaram média de 21,79±4,74 e de 47,95 ±10,73, respectivamente. Foi observada presença de correlação moderada e negativa entre: Tinetti (equilíbrio, marcha e total) x idade; Tinetti (equilíbrio, marcha e total) x IMC; Berg x IMC; Tinetti Equilíbrio x Berg e Tinetti Marcha x Berg. Já entre o Tinetti Total x Berg foi percebido uma correlação positiva e forte. Em todos os cruzamentos entre a atividade física e as variáveis das escalas do estudo, pode-se perceber que a distribuição das variáveis é semelhante em ambos os grupos. Conclusão: Os achados encontrados no presente estudo dão indícios que a idade e o IMC acarretam um declínio do equilíbrio e da marcha em pacientes idosos, e que a OA de joelho é uma condição que também influencia de forma negativa sobre essas duas variáveis. O envelhecimento associado a OA, consequentemente potencializa as perdas do equilíbrio e marcha, pela dor, diminuição da força muscular e estímulos proprioceptivos inadequados dentro da cartilagem articular.

    Dwellings, jabuticabas, and affections — trajectories with Sylvia Caiuby Novaes

    Get PDF
    Sylvia Caiuby Novaes é professora do Departamento de Antropologia da Universidade de São Paulo (USP) e dedica-se há cerca de 50 anos à pesquisa e ao ensino em antropologia. Entre outras realizações, ela é uma das pioneiras da antropologia visual no Brasil, é fundadora do Laboratório de Imagem e Som da Antropologia (LISA) e editora responsável pela revista Gesto, Imagem e Som. Revista de Antropologia (GIS). Nesta entrevista, realizada por mais de 30 orientandos de diferentes gerações, Sylvia fala sobre sua trajetória, projetos, visão de mundo, suas diversas viagens, o fascínio pelas pesquisas de campo e a universidade. Ao contar sobre sua trajetória acadêmica e pessoal, Sylvia traz reflexões sobre sua relação com a fotografia e a produção de imagens.  Sylvia Caiuby Novaes is a Professor in the Department of Anthropology at the University of São Paulo (USP) and has been dedicated to research and teaching in anthropology for nearly 50 years. Among other accomplishments, she is one of the pioneers of visual anthropology in Brazil, is the founder of the Laboratory of Image and Sound of Anthropology (LISA) and the editor in charge of the Gesture, Image and Sound.  Journal of Anthropology (GIS). In this interview, conducted by more than 30 advisees from different generations, Sylvia talks about her trajectory, projects, worldview, her various travels, her fascination with field research and the university. When telling about her academic and personal trajectory, Sylvia reflects on her relationship with photography and the production of images

    Acquired enamel pellicle protects gastroesophageal reflux disease patients against erosive tooth wear

    Get PDF
    Abstract The objective of this study was to compare the protein profile of the acquired enamel pellicle (AEP) formed in vivo in patients with or without gastroesophageal reflux disease (GERD), and with or without erosive tooth wear (ETW). Twenty-four volunteers were divided into 3 groups: 1) GERD and ETW; 2) GERD without ETW; and 3) control (without GERD). The AEP formed 120 min after prophylaxis was collected from the lingual/palatal surfaces. The samples were subjected to mass spectrometry (nLC-ESI-MS/MS) and label-free quantification by Protein Lynx Global Service software. A total of 213 proteins were identified, or 119, 92 and 106 from each group, respectively. Group 2 showed a high number of phosphorylated and calcium-binding proteins. Twenty-three proteins were found in all the groups, including 14-3-3 protein zeta/delta and 1-phosphatidylinositol. Several intracellular proteins that join saliva after the exfoliation of oral mucosa cells might have the potential to bind hydroxyapatite, or participate in forming supramolecular aggregates that bind to precursor proteins in the AEP. Proteins might play a central role in protecting the dental surface against acid dissolution

    Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

    Get PDF
    Background Melphalan flufenamide (melflufen), an alkylating peptide-drug conjugate, plus dexamethasone showed clinical activity and manageable safety in the phase 2 HORIZON study. We aimed to determine whether melflufen plus dexamethasone would provide a progression-free survival benefit compared with pomalidomide plus dexamethasone in patients with previously treated multiple myeloma. Methods In this randomised, open-label, head-to-head, phase 3 study (OCEAN), adult patients (aged ≥18 years) were recruited from 108 university hospitals, specialist hospitals, and community-based centres in 21 countries across Europe, North America, and Asia. Eligible patients had an ECOG performance status of 0–2; must have had relapsed or refractory multiple myeloma, refractory to lenalidomide (within 18 months of randomisation) and to the last line of therapy; and have received two to four previous lines of therapy (including lenalidomide and a proteasome inhibitor). Patients were randomly assigned (1:1), stratified by age, number of previous lines of therapy, and International Staging System score, to either 28-day cycles of melflufen and dexamethasone (melflufen group) or pomalidomide and dexamethasone (pomalidomide group). All patients received dexamethasone 40 mg orally on days 1, 8, 15, and 22 of each cycle. In the melflufen group, patients received melflufen 40 mg intravenously over 30 min on day 1 of each cycle and in the pomalidomide group, patients received pomalidomide 4 mg orally daily on days 1 to 21 of each cycle. The primary endpoint was progression-free survival assessed by an independent review committee in the intention-to-treat (ITT) population. Safety was assessed in patients who received at least one dose of study medication. This study is registered with ClinicalTrials.gov, NCT03151811, and is ongoing. Findings Between June 12, 2017, and Sept 3, 2020, 246 patients were randomly assigned to the melflufen group (median age 68 years [IQR 60–72]; 107 [43%] were female) and 249 to the pomalidomide group (median age 68 years [IQR 61–72]; 109 [44%] were female). 474 patients received at least one dose of study drug (melflufen group n=228; pomalidomide group n=246; safety population). Data cutoff was Feb 3, 2021. Median progression-free survival was 6·8 months (95% CI 5·0–8·5; 165 [67%] of 246 patients had an event) in the melflufen group and 4·9 months (4·2–5·7; 190 [76%] of 249 patients had an event) in the pomalidomide group (hazard ratio [HR] 0·79, [95% CI 0·64–0·98]; p=0·032), at a median follow-up of 15·5 months (IQR 9·4–22·8) in the melflufen group and 16·3 months (10·1–23·2) in the pomalidomide group. Median overall survival was 19·8 months (95% CI 15·1–25·6) at a median follow-up of 19·8 months (IQR 12·0–25·0) in the melflufen group and 25·0 months (95% CI 18·1–31·9) in the pomalidomide group at a median follow-up of 18·6 months (IQR 11·8–23·7; HR 1·10 [95% CI 0·85–1·44]; p=0·47). The most common grade 3 or 4 treatment-emergent adverse events were thrombocytopenia (143 [63%] of 228 in the melflufen group vs 26 [11%] of 246 in the pomalidomide group), neutropenia (123 [54%] vs 102 [41%]), and anaemia (97 [43%] vs 44 [18%]). Serious treatment-emergent adverse events occurred in 95 (42%) patients in the melflufen group and 113 (46%) in the pomalidomide group, the most common of which were pneumonia (13 [6%] vs 21 [9%]), COVID-19 pneumonia (11 [5%] vs nine [4%]), and thrombocytopenia (nine [4%] vs three [1%]). 27 [12%] patients in the melflufen group and 32 [13%] in the pomalidomide group had fatal treatment-emergent adverse events. Fatal treatment-emergent adverse events were considered possibly treatment related in two patients in the melflufen group (one with acute myeloid leukaemia, one with pancytopenia and acute cardiac failure) and four patients in the pomalidomide group (two patients with pneumonia, one with myelodysplastic syndromes, one with COVID-19 pneumonia). Interpretation Melflufen plus dexamethasone showed superior progression-free survival than pomalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma.Oncopeptides ABPeer reviewe

    New insights into the genetic etiology of Alzheimer's disease and related dementias

    Get PDF
    Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

    The genetic architecture of the human cerebral cortex

    Get PDF
    The cerebral cortex underlies our complex cognitive capabilities, yet little is known about the specific genetic loci that influence human cortical structure. To identify genetic variants that affect cortical structure, we conducted a genome-wide association meta-analysis of brain magnetic resonance imaging data from 51,665 individuals. We analyzed the surface area and average thickness of the whole cortex and 34 regions with known functional specializations. We identified 199 significant loci and found significant enrichment for loci influencing total surface area within regulatory elements that are active during prenatal cortical development, supporting the radial unit hypothesis. Loci that affect regional surface area cluster near genes in Wnt signaling pathways, which influence progenitor expansion and areal identity. Variation in cortical structure is genetically correlated with cognitive function, Parkinson's disease, insomnia, depression, neuroticism, and attention deficit hyperactivity disorder
    corecore